Gift Nifty shows Sensex, Nifty to open flat today; Tata Capital listing in focus

1 day ago 5
ARTICLE AD BOX

Sensex, Nifty today: In focus is Tata Capital's listing after raising $1.75 billion in India's largest IPO of 2025. Track latest news on stock market today here

Updated on: Oct 13, 2025 9:02 AM IST

Share

Copy link

  • copy link

India's stock market is likely to open little changed today, with investor focus firmly on the listing of Tata Capital—India's largest IPO of 2025 so far.

The Bombay Stock Exchange building on Dalal Street in Mumbai. (Bloomberg)
The Bombay Stock Exchange building on Dalal Street in Mumbai. (Bloomberg)

Gift Nifty futures were trading 0.41% higher at 25,315 points as of 8:53 am, indicating that the benchmark Nifty 50 will open near Friday's close of 25,285.35.

The Nifty and BSE Sensex gained 1.6% each last week, marking their strongest performance in more than three months, as buoyant sentiment ahead of the earnings season helped attract foreign inflows.

FIIs inflows stood at 2,350 crore last week, supported by a narrowing valuation gap with other emerging markets, optimism around a potential India-US trade deal and hopes of earnings revival.

Meanwhile, investors will turn their attention to Tata Capital's market debut on the day, after the non-banking financial company's IPO raised $1.75 billion last week in a busy primary market.

On Friday, US President Donald Trump promised to sharply hike tariffs on China in a reprisal against its curb on critical mineral exports.

Rising trade tensions between the world's two largest economies could fuel inflation in the U.S. and force the Federal Reserve to delay interest rate cuts.

High U.S. rates do not bode well for emerging market equities as they make dollar and Treasury yields attractive for global investors.

Stocks To Watch Today

  • DMart operator Avenue Supermarts Ltd. posts 3.9% year-on-year rise in consolidated profit in the July-September quarter and 15.5% jump in revenue, but operating margin contracts.
  • Realtor Phoenix Mills says retailer consumption across all operational malls improved sequentially in the September quarter, even residential sales zoomed.
  • Drugmaker Lupin Ltd. says US Food and Drug Administration concluded its pre-approval inspection at a US facility with one observation.

recommendedIcon

Read Entire Article